COPENHAGEN, Denmark, 06 January 2025 – The Board of Directors of DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, announces that the Company will convene an extraordinary general meeting with a proposal to change the nominal value of the shares of the Company …
